NCT04565977已完成不适用
Evaluating Off-label Use of Direct Oral Anticoagulants (DOACs) in Hypercoagulable States
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 42
- 试验地点
- 1
- 主要终点
- Rates of hemorrhagic events during the study period
研究概览
简要总结
Retrospective, cohort study chart review in patients with hypercoagulable states.
详细描述
- Retrospective, cohort study chart review in patients at Methodist Health System
- Data will be pulled on all patients with hypercoagulable states identified by ICD-9/ICD-10 codes from January 1st, 2015 to December 31st, 2019
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients ≥ 18 year-old
- •Patients with diagnosis of hypercoagulable state identified by ICD-9/ICD-10 codes
- •Patients who were prescribed DOACs or VKA for primary or secondary prevention of thrombosis
排除标准
- •Patients with FDA-approved indications of oral anticoagulants including atrial fibrillation or treatment/prevention of thrombotic events unrelated to specified hypercoagulable states
- •Patients with incomplete electronic medical records
结局指标
主要结局
Rates of hemorrhagic events during the study period
时间窗: Jan 1,2015 - Dec 31st, 2019
Rates of hemorrhagic events during the study period
Rates of thrombotic events during the study period
时间窗: Jan 1,2015 - Dec 31st, 2019
Rates of thrombotic events during the study period
次要结局
- Rates of DOAC prescribing for thrombosis prevention in hypercoagulable states(Jan 1,2015 - Dec 31st, 2019)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in JapanNon-Valvular Atrial Fibrillation (NVAF)NCT05027061Bristol-Myers Squibb11,776
终止
不适用
Oral Anticoagulant Peri-procedural Management in Patients Undergoing an Oral Surgery, Implantology or PeriodontologyOral AnticoagulantsInvasive ProcedureNCT03150303Assistance Publique - Hôpitaux de Paris532
已完成
不适用
Medical Need of OAC ReversalAtrial FibrillationNCT03254147Boehringer Ingelheim53,969
招募中
不适用
Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary InterventionAnticoagulantsAtrial FibrillationCoronary Artery DiseaseNCT04977076Zuyderland Medisch Centrum1,270
已完成
不适用
Evaluation of Safety and Effectiveness on Oral AnticoagulantsAtrial FibrillationNCT03765242Bristol-Myers Squibb12,354